To determine the specificity of plasma KARS1 level in CRC, the levels of KARS1, CEA, and CA 19-9 were also measured by ELISA in the plasma of pancreatic cancer (PC) patients (n = 30) (Figure S1A–E). This evidence concerns the gene CEACAM5 and pancreatic neoplasm.